Cargando…
Anti-PAI-1 Monoclonal Antibody Inhibits the Metastasis and Growth of Esophageal Squamous Cell Carcinoma
Plasminogen activator inhibitor (PAI-1) is highly expressed in esophageal squamous cell carcinoma (ESCC) and strongly contributes to metastasis, making it a potential target for ESCC therapy. However, the antibodies and inhibitors targeting PAI-1 have not shown good therapeutic effect in the in vivo...
Autores principales: | Zheng, Yutian, Meng, Lin, Qu, Like, Zhao, Chuanke, Wang, Lixin, Liu, Caiyun, Shou, Chengchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809335/ https://www.ncbi.nlm.nih.gov/pubmed/36605486 http://dx.doi.org/10.7150/jca.77888 |
Ejemplares similares
-
Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis
por: Zhao, Chuanke, et al.
Publicado: (2015) -
Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion
por: Liu, Caiyun, et al.
Publicado: (2018) -
Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma
por: Sun, Shuning, et al.
Publicado: (2023) -
Correction: Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
por: Chen, Shanmei, et al.
Publicado: (2022) -
Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
por: Chen, Shanmei, et al.
Publicado: (2021)